A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer

Clinical trial NCT07544056 · RECRUITING

Trial details

NCT number: NCT07544056
Sponsor: BeBetter Med Inc
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Locally Advanced Triple-negative Breast Cancer Metastatic Triple-negative Breast Cancer

Start date: 2026-06-04
Primary completion: 2030-06-01
Enrollment: 446

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.